• Nutrition Research and Practice
• /
• 제10권5호
• /
• pp.501-506
• /
• 2016

BACKGROUNG/OBJECTIVES: Corn silk (CS) extract contains large amounts of maysin, which is a major flavonoid in CS. However, studies regarding the effect of CS extract on cholesterol metabolism is limited. Therefore, the purpose of this study was to determine the effect of CS extract on cholesterol metabolism in C57BL/6J mouse fed high-fat diets. MATERIALS/METHODS: Normal-fat group fed 7% fat diet, high-fat (HF) group fed 25% fat diet, and high-fat with corn silk (HFCS) group were orally administered CS extract (100 mg/kg body weight) daily. Serum and hepatic levels of total lipids, triglycerides, and total cholesterol as well as serum free fatty acid, glucose, and insulin levels were determined. The mRNA expression levels of acyl-CoA: cholesterol acyltransferase (ACAT), cholesterol 7-alpha hydroxylase (CYP7A1), farnesoid X receptor (FXR), lecithin cholesterol acyltransferase (LCAT), low-density lipoprotein receptor, 3-hyroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), adiponectin, leptin, and tumor necrosis factor ${\alpha}$ were determined. RESULTS: Oral administration of CS extract with HF improved serum glucose and insulin levels as well as attenuated HF-induced fatty liver. CS extracts significantly elevated mRNA expression levels of adipocytokines and reduced mRNA expression levels of HMG-CoA reductase, ACAT, and FXR. The mRNA expression levels of CYP7A1 and LCAT between the HF group and HFCS group were not statistically different. CONCLUSIONS: CS extract supplementation with a high-fat diet improves levels of adipocytokine secretion and glucose homeostasis. CS extract is also effective in decreasing the regulatory pool of hepatic cholesterol, in line with decreased blood and hepatic levels of cholesterol though modulation of mRNA expression levels of HMG-CoA reductase, ACAT, and FXR.

• 한국응용과학기술학회지
• /
• 제35권3호
• /
• pp.654-666
• /
• 2018

본 연구는 비만 모델동물 랫드에서 식이 내 오메가 6와 3 지방산 비율(n-6/n-3 0, 4:1, 15:1, 30:1)이 지질대사의 생화학적 메카니즘을 구명하였다. 혈액 중성지방은 대조군과 비교할 때 n-6/n-3 비율 4:1, 15;1, 30:1 처리군에서 22.21%, 총콜레스테롤 20.60%, LDL-C 52.96%, 혈당 15.71%, ALT 11.97%, AST 9.13%, 인슐린 37.57%, 렙틴 45.98% 낮아졌으나, HDL-C 28.38%, 인지질 80.39% 증가하였고, 특히 4:1 처리군에서 가장 큰 효과가 나타났다. 간 조직에서 SREPB-$1{\alpha}$, SREPB-2 mRNA는 대조군과 비교할 때 n-6/n-3 비율 처리군에서 하향조절 하였으나 PPARs 그리고 지방조직의 LPL-mRNA는 상향조절 하였다. 간 조직에서 지방세포의 크기는 n-6/n-3 비율 30:1, 대조군, 15:1, 4:1 순서로 낮아졌고, 지방조직에서 지방세포의 크기는 대조군, 30:1, 15:1, 4:1 순서로 낮았다. 결과는 비만 모델동물 랫드에서 오메가 6와 오메가 3 지방산 비율, 특히 4:1을 함유하는 식이를 급여하면 혈액 유해 지질, 간 기능 효소, 렙틴, 인슐린, 간과 지방조직의 유전자 발현 조절을 통하여 건강을 유지할 수 있다는 새로운 사실을 발견하였다.

• 한국응용과학기술학회지
• /
• 제37권5호
• /
• pp.1125-1137
• /
• 2020

본 연구는 암컷 쥐의 난소절제 후 고지방식이로 비만이 유도된 비만 쥐에서 수영운동이 지방조직에서 염증반응을 억제하는지를 조사하였다. 실험군과 대조군은 모의수술군(Sham), 난소절제 수술군(OVX) 및 수영운동을 실시한 난소절제 수술군(OVX/Ex)으로 구분되어 8주 동안 고지방식이(45% fat) 사료를 섭취하면서 사육되었다. 생식기 주변 지방조직, 복막 신장주변 지방조직, 및 장간막 지방조직을 포함한 내장지방조직의 무게는 Sham에 비해 OVX에서 증가하였으나, OVX에 비해 OVX/Ex에서는 감소하였다. Sham에 비해 OVX는 지방조직에서의 IκBα의 유전자 발현이 감소하였고 염증성 사이토카인(IL-6, MCP-1, TNF-α 및 leptin)의 유전자 발현은 증가하였다. OVX에 비해 OVX/Ex는 지방조직에서의 IκBα이 증가하였고 염증성 사이토카인의 유전자 발현은 감소하였다. 결론적으로 본 연구는 난소절제 후 고지방식이로 비만이 유도된 비만 쥐에서 수영 운동은 지방조직에서 염증반응을 억제함으로써 비만의 예방과 치료에 효과적이다는 것을 제시하였다.

• Food Science and Biotechnology
• /
• 제16권6호
• /
• pp.910-917
• /
• 2007

The aim of this study is to determine the anti-obesity effects of genistein and exercise, separately and in combination, in mice. Fifty male C57BL/6J mice were divided into 5 treatment groups: normal diet (ND), high fat diet (HD), high fat diet with exercise (HD+Ex), high fat diet with 0.2% genistein (HD+G), high fat diet with 0.2% genistein, and exercise (HD+G+Ex). They were allowed free access to feed and water, and exercised mice engaged in swimming on a regular basis for 12 weeks. Genistein supplemented mice gained less weight, had lower energy intake, better lipid profiles, and lower leptin than the HD mice. Furthermore, when genistein was combined with exercise (HD+G+Ex) the effects were even greater. HD, HD+Ex, and HD+G mice exhibited increased hepatic CPT-1 mRNA expression. Therefore, genistein and exercise has anti-obesity effects, as shown by changes in body weight, fat accumulation, energy intake, and leptin levels.

• 약학회지
• /
• 제44권5호
• /
• pp.391-398
• /
• 2000

Leptin, the product of the ob gene, is a small peptide molecule synthesized by white adipocytes with an important role in the regulation of body fat and food intake. Based on the evidence that synthesis of leptin is regulated by female sex hormone, estrogen, this present study was investigated whether sex hormone precursor DHEA, can regulate obese gene expression in lean and genetically obese (ob/ob) mice. Antiobesity activity of DHEA was evaluated by determining body weight, food consumption, epididymal fat weight and serum levels of cholesterol and triglyceride in ICR, C57BL/6J, and ob/ob mice. The treatment of C57BL/6J lean and obese mice with a diet containing 0.3% and 0.6% DHEA resulted in lowered rates of weight gain in comparison to non-treated mice, although much greater response was found in the obese mice. All other concentrations of DHEA (0.015%, 0.06%, 0.15%, 0.3%) except the highest one(0.6%) showed no significant effects on weight gain in ICR mice. Food consumption was significantly decreased in all mice treated with 0.6% DHEA, whereas it was not decreased in ICR mice at lower concentrations than 0.6% DHEA. DHEA decreased significantly epididymal adipose tissue weight and serum triglyceride levels dose dependently in lean and obese mice. However serum cholesterol levels were decreased at lower concentrations than 0.15% DHEA and increased at concentrations of 0.3% and 0.6% DHEA in lean and obese mice. These increases in serum cholestrol levels at high concentrations of DHEA might result from the fact that DHEA has a cholesterol moiety thereby interfered the assay system. As an approach to elucidate the mechanism for antiobesity activity of DHEA, we examined mRNA levels of obese gene in the adipocyte and obese gene product (leptin) in the serum. The results showed that DHEA did not affect obese gene expression in ICR and C57BL/6J mice. Therefore, we concluded that antiobesity activity of DHEA was not modulated by obese gene expression.

• 한국식품영양과학회지
• /
• 제41권7호
• /
• pp.895-900
• /
• 2012

본 연구에서 동과 물추출물의 계통분획을 통해 획득된 세가지 분획물인 핵산 분획(BHHH), 클로로포름 분획(BHHC), 에틸아세테이트 분획(BHHE)들을 3T3-L1 분화과정 중에 처리한 후, Oil Red O 염색법에 의한 lipid accumulation, 지방구내 triglyceride 함량을 평가하고, free glycerol release 함량과 adipogenesis와 관련된 transcription factor들의 발현 함량을 비교하여 동과 물추출물 중 anti-adipogenesis 활성 분획물을 밝히고, 이 분획물의 작용 메커니즘을 규명하고자 하였다. 50 ${\mu}g/mL$ 농도의 BHHC와 BHHE의 처리는 분화된 지방세포 내 지질 축척을 11%와 13%로 낮추었다. 지방세포 내 중성지방(TG)의 함량은 동일 농도의 각 분획물에서 21%와 16%로 낮게 나타났다. TG 함량의 감소와 지방구내 지질 축적의 감소, 즉 anti-adipogenesis 메커니즘을 밝히기 위해 free glycerol 분비량을 평가하였다. 동일 농도의 BHHC와 BHHE에서 각각 13%와 17% 감소되어 나타났다. BHHC와 BHHE는 세포가 분화하는 동안 $PPAR{\gamma}$, C/$EBP{\alpha}$, leptin의 mRNA 발현을 억제하는 것으로 나타났다. 특히 BHHE의 경우 각 transcriptional factor들의 발현을 45%, 67%, 35%로 현저히 억제시키는 우수한 anti-adipogenetic 소재로 나타났다. 이에 BHHE는 항비만 기능성 소재로 활용될 수 있을 것으로 판단된다.

• BMB Reports
• /
• 제42권4호
• /
• pp.194-199
• /
• 2009

The effects of the ginsenoside Rb2 (Rb2) on lipid metabolism were characterized in 3T3-L1 adipocytes to evaluate their utility for treating obesity. While the amounts of total cholesterol and triacylglycerol (TAG) were markedly increased in the adipocytes treated with high amounts of cholesterol and fetal bovine serum (FBS), the test groups treated with Rb2 showed levels that were close to normal. The effect of Rb2 on these cells was comparable to that of lovastatin. Rb2 enhanced the expression of the sterol regulated element binding protein (SREBP) mRNA whereas treatment with cholesterol and FBS led to a reduction in the abundance of this transcript. The activity of fatty acid synthetase (FAS) was lower in the cholesterol group compared to the Rb2 treatment group suggesting that the observed decrease in cholesterol levels and activated SREBP was mediated by Rb2. Treatment with Rb2 also resulted in a decrease in TAG levels in adipocytes cultured under high fatty acid conditions. This effect was mediated by stimulating the expression of SREBP and Leptin mRNA, suggesting that Rb2 might be a valuable component capable of lowering the levels of lipids.

• 대한의생명과학회지
• /
• 제14권3호
• /
• pp.131-137
• /
• 2008

Adipogenesis is a complex sequence of events that culminates in the differentiation of fibroblast-like preadipocytes into specialized lipid-filled adipocytes and also involves a cascade of expression of many transcription factors such as peroxisome proliferator-activated receptor ${\gamma}(PPAR{\gamma})$ and CCAAT/enhancer-binding proteins (C/EBPs). $PPAR{\gamma}$ and C/EBPs transcriptionally transactivate adipocyte specific genes, including fatty acid transport protein (FAT/CD36) and leptin. To determine whether $17{\beta}$-estradiol modulates $C/EBP{\alpha}$ actions on adipogenesis in high fat diet-fed female ovariectomized (OVX) C57BL/6 mice, mice were treated with $17{\beta}$-estradiol for 7 days and the effects of $17{\beta}$-estradiol on adipose tissue mass and expression of adipocyte specific gene as well as $C/EBP{\alpha}$ were measured. Compared to vehicle-treated OVX control mice, OVX mice treated with $17{\beta}$-estradiol for 7 days had lower adipose tissue weights that were similar to weights in high fat diet-fed sham-operated (Sham) mice. OVX mice showed the increased expression of $C/EBP{\alpha}$ mRNA compared with Sham mice. However, $17{\beta}$-estradiol treatment in OVX mice inhibited OVX induced-$C/EBP{\alpha}$ activation, indicating that $17{\beta}$-estradiol may act as an inhibitor of $C/EBP{\alpha}$ action. Moreover, $17{\beta}$-estradiol decreased mRNA levels of adipocyte marker genes, such as lipoprotein lipase, FAT/CD36 and leptin, to levels in Sham mice. These results suggest that down-regulation of adipogenesis by $17{\beta}$-estradiol may be due to reduced adipose $C/EBP{\alpha}$ activities in female OVX C57BL/6 mice.

• 사상체질의학회지
• /
• 제28권2호
• /
• pp.147-162
• /
• 2016

Objectives The objective of this study is to develop a taeeumin animal-experimental model induced lung fibrosis with Bleomycin and evaluate the effect on obesity in this animal-experimental model.Methods The subjects were divided into 3 groups : normal group, high fat diet(HFD) control group, and HFD group administered with bleomycin(n=10 per group). To develop taeeumin animal-experimental model with reduced respiratory metabolism, 8-week-old C57BL/6 mice were administered with 0.03ml solution of bleomycin 1U/ml dissolved in distilled water, intratracheal(IT), once. Then, the HFD control group and the experimental group were fed with high fat diet for 6 weeks. Airway hyperresponsiveness(AHR) to methacholine was measured at the 1st and 3rd week after bleomycin was administered. Food intake and body weight were measured at regular time weekly. After the final experiment, blood was gathered by cardiac puncture for bloodchemical examination and organs(liver, fatty tissue) were remoed, weighted, and mRNA was analyzed.Results and Conclusions Through the experiment, it was found that Bleomycin induced Taeeumin animal-experimental models have leptin resistace. In the experimental group administered with Bleomycin, fatty acid synthesizing gene expression increased and energy metabolizing gene expression decreased. As mRNA expression of adiponectin decreased, it was found that Taeeuim animal-experimental model is susceptible to metabolic syndrome and cardiovascular diseases.

• Molecules and Cells
• /
• 제38권12호
• /
• pp.1044-1053
• /
• 2015

This study first investigated the effects of corn gluten hydrolysate (CGH) (1.5 g/day) administration for 7 days on appetite-responsive genes in lean Sprague-Dawley (SD) rats. In a second set of experiments, the metabolic changes occurring at multiple time points over 8 weeks in response to CGH (35.33% wt/wt) were observed in high-fat (HF, 60% of energy as fat) diet-fed SD rats. In lean rats, the hypothalamus neuropeptide-Y and proopiomelanocortin mRNA levels of the CGH group were significantly changed in response to CGH administration. In the second part of the study, CGH treatment was found to reduce body weight and perirenal and epididymal fat weight. CGH also prevented an increase in food intake at 2 weeks and lowered plasma leptin and insulin levels in comparison with the HF group. This reduction in the plasma and hepatic lipid levels was followed by improved insulin resistance, and the beneficial metabolic effects of CGH were also partly related to increases in plasma adiponectin levels. The Homeostasis Model of Assessment - Insulin Resistance (HOMA-IR), an index of insulin resistance, was markedly improved in the HF-CGH group compared with the HF group at 6 weeks. According to the microarray results, adipose tissue mRNA expression related to G-protein coupled receptor protein signaling pathway and sensory perception was significantly improved after 8 weeks of CGH administration. In conclusion, the present findings suggest that dietary CGH may be effective for improving hyperglycemia, dyslipidemia and insulin resistance in diet-induced obese rats as well as appetite control in lean rats.